Skip to main content
English
Français
Search form
Search
Follow this Company
|
Contact
Home
At a Glance
Products
Oncology
GRN1005
Pain
ANG2002
ANG2010
Type 2 Diabetes and Obesity
ANG2004
CNS: Parkinson's Disease
ANG2008
EPiC Technology
The Challenge
The LRP-1 Solution
About
Management Team
Board of Directors
Advisory Boards
Investors
Careers
Contact
Partnering
Our Partners
Media Center
In the News
News Releases
Events
Publications
Media Inquiries
You are here
Home
»
Media Center
» News Releases
News Releases
2011
GERON INITIATES PHASE 2 TRIAL OF GRN1005 IN BRAIN METASTASES FROM LUNG CANCER
27-Dec-2011
GERON INITIATES PHASE 2 TRIAL OF GRN1005 IN BRAIN METASTASES FROM BREAST CANCER
16-Dec-2011
GERON PRESENTS FINAL PHASE 1 CLINICAL DATA ON GRN1005 AT AACR-NCI-EORTC
15-Nov-2011
ANGIOCHEM PRESENTS DATA DEMONSTRATING THE BROAD APPLICABILITY OF ITS EPiC TECHNOLOGY TO CROSS THE BLOOD BRAIN BARRIER
24-Oct-2011
ANGIOCHEM TO PRESENT AT STIFEL NICOLAUS 2011 HEALTHCARE CONFERENCE
01-Sep-2011
Angiochem granted U.S. patent for transporting drug compounds across the blood-brain barrier, using novel EPiC technology
14-Mar-2011
Angiochem receives Innovation Award from the National Brain Tumor Society for advancing the development of novel brain cancer treatments
15-Feb-2011
2010
Angiochem announces plans for advancing product candidates from proprietary platform
08-Dec-2010
Geron expands clinical oncology pipeline with license and collaboration agreements with Angiochem
06-Dec-2010
Angiochem to Present at Stifel Nicolaus Healthcare Conference 2010
15-Sep-2010
Angiochem appoints David Scheer to its Board Of Directors
02-Jun-2010
Angiochem to participate in 2010 Bio International Convention
28-Apr-2010
Angiochem presents data further demonstrating the role of LRP-1 in cancer
20-Apr-2010
Angiochem to present data for oncology programs at American Association for Cancer Research Meeting
12-Apr-2010
Preclinical data on new Angiochem oncology programs published in Journal of Medicinal Chemistry
31-Mar-2010
Angiochem to present at Cowen and Company 30th Annual Health Care Conference
05-Mar-2010
2009
Angiochem’s ANG1005 demonstrates safety and efficacy in Phase 1/2 brain cancer studies
18-Oct-2009
New research helps therapies get around, through blood-brain barrier (press release issued at Neuroscience 2009)
18-Oct-2009
Angiochem to present new clinical data for ANG1005 in brain cancers at Society for Neuroscience meeting.
08-Oct-2009
AngioChem Granted First U.S. Patent Covering Angiopep-2, an Engineered Peptide for Drugs to Cross the Blood-Brain Barrier.
09-Jul-2009
New Positive Clinical Data on ANG1005 for Brain Cancers at AACR
21-Apr-2009
AngioChem to Present New ANG1005 Clinical Data at AACR
07-Apr-2009
AngioChem's ANG1005 Shows Promise In theTreatment of Brain Cancers.
19-Mar-2009
2008
AngioChem to present at the 20th Annual Piper Jaffray Health Care Conference
01-Dec-2008
ANG1005 Demonstrates Preliminary Clinical Safety and Tolerability in Brain Cancer Patients.
22-Oct-2008
AngioChem announces two new peer-reviewed publications.
10-Jul-2008
AngioChem receives the BIOMATCH Award during the 2008 BioMedex meeting
25-Apr-2008
In the News
News Releases
Events
Publications
Media Inquiries
